Femtosecond infrared laser - An efficient and safe in vivo gene delivery system for prolonged expression

Molecular Therapy

Volumn 8, Issue 2, 2003, Pages 342-350

  Zeira, Evelyne ^a   Manevitch, Alexandra ^a   Khatchatouriants, Artium ^a   Pappo, Orit ^a   Hyam, Esti ^a   Darash Yahana, Merav ^a   Tavor, Einat ^b   Honigman, Alik ^b   Lewis, Aaron ^a   Galun, Eithan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

Electroporation; Gene expression in vivo; Gene therapy; Naked DNA; Nonviral vectors

Indexed keywords

ERYTHROPOIETIN; NAKED DNA; PLASMID VECTOR; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARGON LASER; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; ELECTROPORATION; FEMALE; GENE EXPRESSION; GENE TECHNOLOGY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOCRIT; HISTOPATHOLOGY; IN VIVO STUDY; INFRARED RADIATION; METHODOLOGY; MOUSE; MUSCLE INJURY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PROCESS OPTIMIZATION; REPRODUCIBILITY; TIBIALIS ANTERIOR MUSCLE; TISSUE INJURY;

ANIMALIA; MURINAE; RODENTIA;

EID: 10744227154     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00184-9     Document Type: Article

References (30)

1. Pfeifer, A., and Verma, I. M. (2001). Gene therapy: Promises and problems. Annu. Rev. Genom. Hum. Genet. 2: 177-211.
2. Aiuti, A., et al. (2002). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296: 2410-2413.
3. Hacein-Bey-Abina, S., et al. (2002). Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346: 1185-1193.
4. Somia, N., and Verma, I. M. (2000). Gene therapy: Trials and tribulations. Nat. Rev. Genet. 1: 91-99.
5. Luo, D., and Saltzman, W. M. (2000). Synthetic DNA delivery systems. Nat. Biotechnol. 18: 33-37.
6. Somiari, S., et al. (2000). Theory and in vivo application of electroporative gene delivery. Mol. Ther. 2: 178-187.
7. Taniyama, Y., et al. (2002). Development of safe and efficient novel nonviral gene transfer using ultrasound: Enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther. 9: 372-380.
8. Mikszta, J. A., Alarcon, J. B., Brittingham, J. M., Sutter, D. E., Pettis, R. J., and Harvey, N. G. (2002). Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat. Med. 8: 415-419.
9. Opalinska, J. B., and Gewirtz, A. M. (2002). Nucleic-acid therapeutics: Basic principles and recent applications. Nat. Rev. Drug Discovery 1: 503-514.
10. Sullenger, B. A., and Gilboa, E. (2002). Emerging clinical applications of RNA. Nature 418: 252-258.
11. Duchler, M., et al. (2002). Somatic gene transfer into the lactating ovine mammary gland. J. Gene Med. 4: 282-291.
12. Honigman, A., et al. (2001). Imaging transgene expression in live animals. Mol. Ther. 4: 239-249.
13. Durieux, A. C., Bonnefoy, R., Manissolle, C., and Freyssenet, D. (2002). High-efficiency gene electrotransfer into skeletal muscle: Description and physiological applicability of a new pulse generator. Biochem. Biophys. Res. Commun. 294: 443-450.
14. Ortiz-Urda, S., et al. (2002). Stable nonviral genetic correction of inherited human skin disease. Nat. Med. 9: 1166-1170.
15. Ferber, D. (2001). Gene therapy: Safer and virus-free? Science 294: 1638-1642.
16. Woolf, T. M. (1998). Therapeutic repair of mutated nucleic acid sequences. Nat. Biotechnol. 16: 341-344.
17. Yant, S. R., Meuse, L., Chiu, W., Ivics, Z., Izsvak, Z., and Kay, M. A. (2000). Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat. Genet. 25: 35-41.
18. Bartlett, R. J., et al. (2000). In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide. Nat. Biotechnol. 18: 615-622.
19. Lewin, M., et al. (2000). Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18: 410-414.
20. Rebuffat, A., et al. (2001). Selective enhancement of gene transfer by steroid-mediated gene delivery. Nat. Biotechnol. 19: 1155-1161.
21. Zhang, G., Budker, V., Williams, P., Subbotin, V., and Wolff, J.A. (2001). Efficient expression of naked DNA delivered intraarterially to limb muscles of nonhuman primates. Hum. Gene Ther. 12: 427-438.
22. Endoh, M., et al. (2002). Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound. Mol. Ther. 5: 501-508.
23. Bettan, M., et al. (2000). High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol. Ther. 2: 204-210.
24. Lefesvre, P., Attema, J. and, and Van Bekkum, D. (2002). A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer. BMC Mol. Biol. 3: 12.
25. Deng, H., Lin, Q., and Khavari, P. A. (1997). Sustainable cutaneous gene delivery. Nat. Biotechnol. 15: 1388-1391.
26. Babiuk, S., et al. (2002). Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 20: 3399.
27. Tirlapur, U. K., and Konig, K. (2002). Targeted transfection by femtosecond laser. Nature 418: 290-291.
28. Lavon, I., et al. (2000). High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation. Nat. Med. 6: 573-577.
29. Duguez, S., Feasson, L., Denis, C., and Freyssenet, D. (2002). Mitochondrial biogenesis during skeletal muscle regeneration. Am. J. Physiol. Endocrinol. Metab. 282: E802-809.
30. Blair-Parks, K., Weston, B. C., and Dean, D. A. (2002). High-level gene transfer to the cornea using electroporation. J. Gene Med. 4: 92-100.